Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B5G2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 43 | 47 | PF00656 | 0.329 |
CLV_NRD_NRD_1 | 119 | 121 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 77 | 79 | PF00675 | 0.488 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.571 |
CLV_PCSK_KEX2_1 | 119 | 121 | PF00082 | 0.555 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.595 |
CLV_PCSK_PC7_1 | 77 | 83 | PF00082 | 0.557 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.614 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.610 |
CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.531 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.559 |
DOC_MAPK_gen_1 | 151 | 161 | PF00069 | 0.637 |
DOC_MAPK_gen_1 | 81 | 90 | PF00069 | 0.562 |
DOC_MAPK_MEF2A_6 | 154 | 161 | PF00069 | 0.475 |
DOC_MAPK_RevD_3 | 116 | 130 | PF00069 | 0.596 |
DOC_PP2B_LxvP_1 | 10 | 13 | PF13499 | 0.509 |
DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.592 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.462 |
LIG_14-3-3_CanoR_1 | 101 | 109 | PF00244 | 0.606 |
LIG_14-3-3_CanoR_1 | 166 | 174 | PF00244 | 0.496 |
LIG_Actin_WH2_2 | 114 | 131 | PF00022 | 0.304 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.711 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.539 |
LIG_FHA_1 | 123 | 129 | PF00498 | 0.330 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.579 |
LIG_FHA_2 | 171 | 177 | PF00498 | 0.464 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.524 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.623 |
LIG_PDZ_Class_2 | 178 | 183 | PF00595 | 0.563 |
LIG_Rb_pABgroove_1 | 116 | 124 | PF01858 | 0.571 |
LIG_SH2_PTP2 | 17 | 20 | PF00017 | 0.333 |
LIG_SH2_STAP1 | 122 | 126 | PF00017 | 0.444 |
LIG_SH2_STAP1 | 31 | 35 | PF00017 | 0.561 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.598 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.563 |
LIG_SH3_1 | 48 | 54 | PF00018 | 0.383 |
LIG_SH3_3 | 48 | 54 | PF00018 | 0.367 |
LIG_SUMO_SIM_par_1 | 107 | 112 | PF11976 | 0.374 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.686 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.601 |
MOD_CK2_1 | 170 | 176 | PF00069 | 0.475 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.503 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.675 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.628 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.666 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.519 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.651 |
MOD_LATS_1 | 36 | 42 | PF00433 | 0.309 |
MOD_N-GLC_1 | 97 | 102 | PF02516 | 0.716 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.652 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.608 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.403 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.313 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.582 |
MOD_PIKK_1 | 56 | 62 | PF00454 | 0.593 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.576 |
MOD_PKA_2 | 162 | 168 | PF00069 | 0.595 |
MOD_Plk_1 | 114 | 120 | PF00069 | 0.471 |
MOD_Plk_1 | 122 | 128 | PF00069 | 0.466 |
MOD_Plk_1 | 170 | 176 | PF00069 | 0.519 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.512 |
MOD_SUMO_rev_2 | 145 | 150 | PF00179 | 0.647 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.375 |
TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.628 |
TRG_ER_diArg_1 | 118 | 120 | PF00400 | 0.538 |
TRG_NES_CRM1_1 | 61 | 76 | PF08389 | 0.562 |
TRG_NLS_Bipartite_1 | 119 | 133 | PF00514 | 0.613 |
TRG_Pf-PMV_PEXEL_1 | 119 | 123 | PF00026 | 0.558 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P774 | Leptomonas seymouri | 61% | 100% |
A0A0S4J6R9 | Bodo saltans | 31% | 98% |
A0A0S4KRE5 | Bodo saltans | 31% | 100% |
A0A1X0PA28 | Trypanosomatidae | 38% | 100% |
A0A3Q8IIW0 | Leishmania donovani | 86% | 100% |
A0A3R7M5H7 | Trypanosoma rangeli | 39% | 92% |
A4HB90 | Leishmania braziliensis | 75% | 100% |
A4IAD8 | Leishmania infantum | 85% | 100% |
C9ZLV7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
Q4Q2H3 | Leishmania major | 84% | 100% |